Buscar
Mostrando ítems 21-26 de 26
A clinical predictive score for mood disorder risk in low-income primary care settings
(CIENCIAS, 2013)
BACKGROUND: Despite availability of validated screening tests for mood disorders, busy general practitioners (GPs) often lack the time to use them routinely. This study aimed to develop a simplified clinical predictive ...
Detecting mood disorder in resource-limited primary care settings: Comparison of a self-administered screening tool to general practitioner assessment
(CIENCIAS, 2013)
Objectives: Although efficacious treatments for mood disorders are available in primary care, under-diagnosis is associated with under-treatment and poorer outcomes. This study compares the accuracy of self-administered ...
Short- and Long-term Survival after Stroke in Hospitalized Patients in Chile: A Nationwide 5-Year Study
(CIENCIAS, 2013)
Background: Short- and long-term stroke survival is a key indicator of hospital performance in stroke care. Our aim was to estimate short-and long-term survival rates in discharged patients diagnosed with ischemic stroke ...
Performance measures for in-hospital care of acute ischemic stroke in public hospitals in Chile
(CIENCIAS, 2013)
Background: The aim of this study were to describe acute care of ischemic stroke patients and adherence to performance measures, as well as the outcomes of these events, in a sample of patients treated in public hospitals ...
Análisis del desempeño de la presencia de células prostáticas malignas circulantes como factor predictivo para la detección de cáncer de próstata en la primera, segunda y tercera biopsia prostática
(CIENCIAS, 2013)
OBJETIVO: El PSA en conjunto con el tacto rectal son los exámenes más utilizados para el cribado de cáncer de próstata (CP), sin embargo, en solo el 30% de estos pacientes se confirma el diagnóstico. En el presente estudio ...
Costo beneficio de la detección de células prostáticas circulantes como test de tamizaje para cáncer de próstata
(CIENCIAS, 2013)
OBJETIVO: El cáncer de próstata es el tumor más frecuente en varones después del cáncer de piel. Para detectar el cáncer prostático en estadios tempranos se realiza despistaje con el antígeno prostático específico (PSA). ...